Nk. Worrall et al., CORTICOSTEROIDS INHIBIT EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASEDURING ACUTE CARDIAC ALLOGRAFT-REJECTION, Transplantation, 61(2), 1996, pp. 324-328
We have recently demonstrated that (1) nitric oxide (NO) is produced d
uring experimental cardiac allograft rejection by the expression of in
ducible nitric oxide synthase (iNOS) in the rejecting organ and that (
2) inhibition of NO production by iNOS attenuated acute rejection. The
present study examined the interaction of corticosteroids, iNOS gene
expression, and iNOS enzyme activity in a rat cardiac transplant model
. Increased NO production in rejecting allografts was demonstrated by
elevated serum nitrite/ nitrate levels (67+/-5 versus 18+/-2 mu M for
isografts; P<0.001) that were significantly reduced by pulse therapy w
ith dexamethasone for 2 days prior to animal sacrifice or continuous d
examethasone treatment (34+/-2 and 19+/-4 mu M, respectively; P<0.001
versus untreated allografts). Increased iNOS enzyme activity was demon
strated in the allograft heart (5.11+/-1.00 versus 0.3+/-0.05 pmol L-c
itrulline mg protein(-1). min(-1) for isografts) and was significantly
reduced with dexamethasone treatment (1.13+/-0.47 for 2-day pulse-tre
ated allografts and 0.02+/-0.01 for continuously treated allografts).
Increased allograft iNOS enzyme activity resulted from induction of iN
OS mRNA expression, which was more than 99% inhibited by dexamethasone
treatment. Dexamethasone pulse therapy reduced but did not eliminate
the histological changes of acute rejection, Thus corticosteroid treat
ment results in inhibition of iNOS expression during allograft rejecti
on. These results further demonstrate that iNOS expression during acut
e rejection is immune-mediated and suggest that the immunosuppressive
actions of corticosteroids in the treatment of acute rejection may inc
lude inhibition of iNOS expression.